Beacon Roofing Supply said on Tuesday it has adopted a limited duration stockholder rights agreement, commonly known as a poison pill, following a hostile takeover bid by QXO. Beacon is issuing one preferred share purchase right for each outstanding share of its common stock to stockholders by way of a dividend,

QXO Inc. has launched a hostile takeover bid for Beacon Roofing Supply Inc. after the board of the building products company rejected its offer as too low.

From Goldman Sachs, Morgan Stanley, Citi, Credit Agricole, Wells Fargo, and Mizuho, among other big financial institutions, QXO has obtained complete finance commitments. These pledges plus QXO's current cash will pay for the whole acquisition price, any required debt refinancing for Beacon, and associated transaction expenses.

M&A specialists are eyeing a robust list of U.S. takeover candidates, with a buoyant economy, strong buyer appetite and a potentially looser regulatory regime seen driving more deals.

Beacon Roofing Supply Inc. has adopted a poison pill defense as the building products company pushes back against a hostile takeover approach from QXO Inc.

Beacon Roofing CEO Julian Francis described communications with a building products distributor looking to acquire his company.

QXO (NYSE:QXO) has commenced an $11B all-cash tender offer to acquire all outstanding shares of Beacon Roofing Supply (NASDAQ:BECN) for $124.25 a share. This price implies a 37% premium above Beacon’s 90-day unaffected volume-weighted average price of $91.

Beacon Roofing Supply said on Tuesday it has adopted a limited duration stockholder rights agreement, commonly known as a poison pill, following a hostile takeover bid by QXO. Beacon is issuing one preferred share purchase right for each outstanding share of its common stock to stockholders,